|
C7ORF60 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40179987009981E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67760000002737E-07 |
| Normal-vs-Stage2 |
4.122500E-03 |
| Normal-vs-Stage3 |
5.560700E-03 |
| Normal-vs-Stage4 |
1.799140E-03 |
| Stage1-vs-Stage2 |
8.537600E-01 |
| Stage1-vs-Stage3 |
9.045000E-01 |
| Stage1-vs-Stage4 |
8.246400E-01 |
| Stage2-vs-Stage3 |
9.436400E-01 |
| Stage2-vs-Stage4 |
9.190000E-01 |
| Stage3-vs-Stage4 |
8.880000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.77159997572352E-09 |
| Normal-vs-AfricanAmerican |
1.51124999999697E-05 |
| Normal-vs-Asian |
1.223180E-01 |
| Caucasian-vs-AfricanAmerican |
5.632800E-01 |
| Caucasian-vs-Asian |
7.682000E-01 |
| AfricanAmerican-vs-Asian |
9.334600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52970000000252E-08 |
| Normal-vs-Female |
2.17610000019519E-08 |
| Male-vs-Female |
4.404200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.264400E-03 |
| Normal-vs-Extreme_Weight |
1.8636799999916E-05 |
| Normal-vs-Obese |
1.2343999999942E-06 |
| Normal-vs-Extreme_Obese |
1.847970E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.243600E-01 |
| Normal_Weight-vs-Obese |
3.736800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.634800E-01 |
| Extreme_Weight-vs-Obese |
6.526600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.442800E-01 |
| Obese-vs-Extreme_Obese |
5.518800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.64909999999363E-05 |
| Normal-vs-Age(41-60Yrs) |
7.04809544060936E-11 |
| Normal-vs-Age(61-80Yrs) |
3.64220000004245E-06 |
| Normal-vs-Age(81-100Yrs) |
1.837360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.267600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.291200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.033800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.291830E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.844780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.565600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.29760654946176E-12 |
| Normal-VS-Type2 PRCC |
4.959600E-02 |
| Normal-VS-KIRP CIMP |
5.141200E-03 |
| Normal-VS-Unclassified PRCC |
7.379700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.16319999999781E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.807800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.348600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.064030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.286400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.641400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.781000E-03 |
| Normal-vs-N1 |
3.943800E-03 |
| Normal-vs-N2 |
1.087820E-02 |
| N0-vs-N1 |
4.983200E-01 |
| N0-vs-N2 |
6.164800E-01 |
| N1-vs-N2 |
8.638800E-01 |
|
|
